-
Symbol
-
MNPR on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Shares Owned
-
522,667 shares
-
Security Ownership %
-
7.8%
AstraZeneca PLC ownership in Monopar Therapeutics Common Stock, par value $0.001 per share (MNPR)
06 Feb 2026 - AstraZeneca PLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 522,667 shares of Monopar Therapeutics Common Stock, par value $0.001 per share (MNPR).
This represents 7.8% ownership of the company.
This is the first filing by ASTRAZENECA PLC disclosing ownership of Monopar Therapeutics Common Stock, par value $0.001 per share (MNPR).